top of page

Perimenopause Meets MCAS. How Rude.

Writer: Dr. Brenda Tapp Leonard, ND
Dr. Brenda Tapp Leonard, ND
Nov 2
4 min read

Your periods are changing. Sleep has become unreliable. You’re suddenly hot, itchy, uncomfortable, or wide awake with a racing heart.


Perimenopause can bring plenty of symptoms on its own. If you also have mast cell activation syndrome (MCAS), figuring out what is happening can become more complicated.


As a naturopathic doctor in Peterborough, I want patients to know that hormones and immune activity can interact. That connection deserves consideration, but it also deserves careful interpretation.


We have biological reasons to suspect that perimenopause can affect mast cell symptoms. We do not yet have direct studies measuring MCAS activity throughout the menopausal transition.


So how do we use that information without making every symptom a mast cell problem or blaming everything on hormones?


Why might MCAS symptoms change during perimenopause?

Perimenopause is the transition leading up to menopause. Hormone production becomes less predictable, ovulation becomes less consistent, and progesterone production can decrease. Estrogen can fluctuate considerably before eventually settling at lower levels.


Mast cells are immune cells that release histamine and other chemical messengers. Experimental research shows that they can respond to sex hormones.


In laboratory studies, estradiol, the main estrogen used in menopausal hormone therapy, has stimulated mast cell mediator release and enhanced certain allergic responses. Progesterone has inhibited histamine release in some experiments.


Clinically, we also know that in women who menstruate regularly, their MCAS symptoms are often worse around high estrogen times in their cycle (ovulation and premenstrually)


That makes hormonal fluctuations a plausible contributor to changing symptoms. It does not establish a simple rule that estrogen is harmful and progesterone is protective in every patient.


Your body is considerably more complicated than a petri dish.


Is it perimenopause, MCAS, or both?

Flushing, disrupted sleep, palpitations, headaches, and changes in concentration can occur during perimenopause. Some also occur in people with mast cell disorders. Itching and digestive symptoms may add to the confusion.


The timing and company a symptom keeps can be helpful.


For example, a wave of heat followed by sweating deserves a different assessment from flushing accompanied by hives, wheezing, diarrhea, or near-fainting. 


Having several overlapping symptoms does not, by itself, confirm MCAS.


Consensus diagnostic criteria consider recurrent episodes involving multiple body systems, objective evidence of mast cell mediator release, and improvement with appropriate treatment. Testing may include tryptase collected during an episode and compared with a baseline sample; selected urinary mediator tests may also be considered by a knowledgeable clinician.


Other explanations, including thyroid disease, iron deficiency, medication effects, and heart rhythm problems, may also need assessment.


Histamine intolerance and MCAS are different concepts, too. A reaction after a particular food, or feeling better with an antihistamine, does not automatically establish either diagnosis.


Can you use HRT if you have MCAS?

MCAS does not automatically rule out hormone replacement therapy (HRT) use for you. It does make an individualized discussion particularly valuable.


HRT, also called menopausal hormone therapy, is an effective treatment for bothersome hot flashes and night sweats. The decision to use it depends on your symptoms, medical history, preferences, and the benefits and risks of the proposed regimen.


What we do not have is controlled research showing how HRT affects people with diagnosed MCAS.


Someone may feel better because their night sweats and sleep disruption improve. Someone else may experience new or increased allergic-type symptoms. An improvement in menopausal symptoms would not necessarily mean that mast cell activity has changed.


What about estrogen?

Laboratory findings give us a reason to monitor hormone-sensitive symptoms when estrogen is introduced or adjusted. They do not prove that prescribed estrogen will cause an MCAS flare.


A prescriber may consider transdermal estradiol, a patch or gel, based on its established benefits and risk profile. Transdermal therapy avoids first-pass liver metabolism and may carry a lower risk of blood clots than oral therapy. It has not been demonstrated to be safer specifically for MCAS.


What about progesterone?

Progesterone’s inhibitory effects in some mast cell experiments are interesting.


They are not sufficient evidence to prescribe it as an MCAS treatment.


Rarely, people develop progestogen hypersensitivity, with reactions associated with their own progesterone or an administered progestogen. Symptoms can include hives, swelling, respiratory symptoms, or anaphylaxis. This is a distinct possibility to investigate when the timing suggests it, not an explanation to assume for every reaction.


Progesterone also has an important role unrelated to mast cells: if you have a uterus and use systemic estrogen, you generally need adequate progestogen protection for the uterine lining. Concerns about tolerability should be discussed with your prescriber rather than managed by simply omitting it.


How do we make treatment less of a guessing game?

Before changing treatment, establish what is already happening. A brief diary can capture:

  • Menstrual bleeding and cycle timing.

  • Flushing, hives, digestive episodes, sleep disruption, and palpitations.

  • Medication doses and recent changes.

  • Suspected triggers and how quickly symptoms follow an exposure.


The goal is to find patterns without turning your life into a full-time research project.


If HRT is appropriate, your prescriber can select a suitable dose and formulation, arrange follow-up, and decide how to introduce changes so that your response is easier to interpret. Known ingredient allergies should also be reviewed.

There is no validated MCAS-specific HRT protocol requiring everyone to start progesterone first, use a particular route, or premedicate. Those decisions need to reflect the individual.


Continue your existing MCAS care unless your treating clinician recommends a change. Severe reactions require your established emergency plan; breathing difficulty, throat swelling, or collapse require immediate emergency care.


Perimenopause and MCAS support in Peterborough

You deserve more than being told that everything is “just hormones.” You also deserve an assessment that leaves room for more than one explanation.


At Peterborough Centre of Naturopathic Medicine, we take an evidence-informed, individualized approach to complex symptoms and perimenopause care. That includes discussing appropriate investigations, reviewing treatment options, and coordinating with other healthcare providers when needed.


If you’re looking for a naturopath in Peterborough to discuss perimenopause, suspected mast cell symptoms, or questions about HRT, book a consultation.


  • Dr Brenda ND



Comments


Contact

  • Instagram
  • Facebook

386 Burnham Street
Peterborough, Ontario
K9H 1T6

Phone: 705-761-6596

Fax: 705-201-5234

health@pcnm.ca

​

Free parking available

behind the building

Working Hours

MONDAY TO FRIDAY : 9AM - 5PM

Appointments available outside these hours, depending on practitioner availability.

Order supplements from our online store

Subscribe to our mailing list

© 2023 Peterborough Centre of Naturopathic Medicine

design by brandbetter

bottom of page